(Q43292843)

18 November 2017

title

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes (English)

1 reference

18 November 2017

Andrea Remuzzi

10

0 references

Ariela Benigni

object named as

Ariela Benigni

series ordinal

12

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

series ordinal

11

0 references

Daniela Corna

series ordinal

2

object named as

Daniela Corna

1 reference

18 November 2017

3

Carla Zoja

1 reference

18 November 2017

7

Sara Conti

1 reference

18 November 2017

8

Daniela Rottoli

1 reference

18 November 2017

9

Lorena Longaretti

1 reference

18 November 2017

1

Elena Gagliardini

1 reference

18 November 2017

4

Fabio Sangalli

1 reference

18 November 2017

5

Fabiola Carrara

1 reference

18 November 2017

Matteo Rossi

6

1 reference

18 November 2017

publication date

12 August 2009

1 reference

American Journal of Physiology - Renal Physiology

18 November 2017

published in

1 reference

18 November 2017

volume

297

1 reference

18 November 2017

issue

5

1 reference

18 November 2017

page(s)

F1448-56

1 reference

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Regression of renal vascular fibrosis by endothelin receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Effect of angiotensin II antagonism on the regression of kidney disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Clinical practice. Nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Size and charge selectivity of the glomerular filter in early experimental diabetes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

The podocyte's response to injury: role in proteinuria and glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Molecular basis of glomerular permselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

The spectrum of podocytopathies: a unifying view of glomerular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Transcriptional Regulation of Nephrin Gene by Peroxisome Proliferator-Activated Receptor- Agonist: Molecular Mechanism of the Antiproteinuric Effect of Pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2009

10.1152/AJPRENAL.00340.2009

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference